Antiparkinson Drugs Flashcards

1
Q

cardinal features of parkinsons

A

resting tremor, muscular rigidity, bradykinesia, gait impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

principal metabolite of dopamine

A

HVA - homovanillic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what do the D1 and D2 receptors do

A
  • D1: activated adenylyl cyclase

- D2: inhibits adenylyl cyclase, opens K+ channels, suppresses Ca2+ currents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

classification of drugs used to treat parkinsons

A

AAIDD

Amantadine
Antimuscarinics
Inhibitors of Dopamine Metabolism: COMT and MAO
Dopamine Precursors
Dopamine Receptor Agonists: Ergot and Non-ergot dopamine agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the dopamine precursor drug

A

Levodopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

mechanism of levodopa

A

transported into the brain by facilitative L transport system –> converted to dopamine in the brain using DOPA decarboxylase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what drug is given with levodopa and why

A

Carbidopa - Dopa decarboxylase inhibitor

  • it does not cross into the brain but works in the periphery by preventing conversion to dopamine in the periphery so that most of the L-DOPA can cause into the brain
  • also conversion to dopamine in periphery –> nausea, vomiting, cardiac arrhythmias, hypotension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is Sinemet

A

preparation containing carbidopa and L-DOPA in fixed preparation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is levodopa’s metabolite

A
homovanillic acid (HVA)
dihydroxyphenylacetic acid (DOPAC)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what happens with long term use of levodopa

A

it is only effective for 3-5 years then responsiveness becomes lost completely

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

AE of levodopa

A
GI effects (dopamine agonists cause nausea and vomiting)
CNS effects (Visual and auditory hallucinations and dyskinesia)
CVS effects (dopamine stimulates heart -- tachycardia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the on-off phenomenon seen with levodopa

A

-off periods of marked akinesia alternate over on periods of improved mobility but often marked dyskinesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

contraindications of levodopa

A

HAV PAMP

  • Hypertensive crisis with Phenelzine or Tranylcypromine (MAOI)
  • Angle closure glaucoma
  • Vitamin B6 (co factor for L-dopa decarboxylase)
  • Psychotic patients esp if on Antipsychotics
  • Arrhythmias in cardiac patients
  • Melanoma
  • Peptic ulcers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the dopamine receptor agonists

A

Ergot derivatives: Bromocriptine

Non ergot derivatives: PARR
Pramipexole
Apomorphine
Ropinirole
Rotigotine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

mechanism of bromocriptine and what is it used to treat

A

D2 agonist

Parkinsons
Hyperprolactinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

mechanisms of the non ergot derivatives dopamine agonist

A

Pramipexole: preferential affinity for D3 receptors
Apomorphine: dopamine agonist
Ropinorole: purely D2 receptor agonist
Rotigotine: transdermal formulation that is dopamine agonist

17
Q

AE of the nonergot dopamine agonists (minus apomorphine)

A
GI effects (nausea and vomiting)
CVS effects
Dyskinesia
Mental disturbances: hallucination etc
Somnolence

harder ones to reason out:
Pulmonary Infiltrates
Pleural and Retroperitoneal Fibrosis
Erythromelalgia

18
Q

long term complication of ergot derivatives dopamine agonist

A

painless digital vasospasm

19
Q

when is apomorphine usually used

A

in off periods of akinesia in patients on dopaminergic therapy

20
Q

since apomorphine is highly emetogenic, what pre treatment is usually used

A

Trimethobenzamide

Domperidone

21
Q

contraindication of apomorphine

A

5-HT3 antagonist -> profound hypotension and loss of consciousness

22
Q

AE of apomorphine

A

QT prolongation

23
Q

what are the inhibitors of dopamine metabolism

A

MAO inhibitors: Selegiline and Rasagiline

COMT inhibitors: Tolcapone and Entacapone

24
Q

what are the MAOIs used for in treatment of parkinson

A
  • Selegeline: selectively inhibits MAO-B so prevents breakdown of dopamine and enhances effect of levodopa (little chance for hypertensive crisis)
  • Rasagiline: prolongs effects of levodopa-carbidopa in parkinson patients
25
what is Selegiline metabolized to and its importance
Methamphetamine and Amphetamine --> insomnia if taken after midafternoon
26
what occurs when carbidopa is used together with levodopa (name the COMT inhibitors)
Tolcapone and Entacapone -firstly inhibition of dopa decarboxylase by carbidopa --> increased in COMT in order to metabolized levodopa --> increases plasma 3-O-methyldopa (3-OMD) --> competes with levodopa for a carrier hence the levodopa that aren't bound are not useful since they don't get into the brain
27
what is mechanism of COMT inhibitors
Tolcapone and Entacapone decrease metabolism of levodopa decreased 3-O-methyldopa (3-OMD) increased uptake of levodopa higher concentration of dopamine in the brain
28
where do the COMT inhibitors exert their effect
Tolcapone in the central and periphery | Entacapone only periphery
29
why is Entacapone preferred over Tolcapone
- not associated with hepatotoxicity (TOLCAPONE LEADS TO HEPATIC NECROSIS) - available as fixed dose with levodopa/carbidopa
30
AE of COMT inhibitors
Entacapone and Tolcapone - increased levodopa: dyskinesias, nausea, vomiting - fulminating hepatic necrosis with Tolcapone (every 2 week monitoring of liver function) - Orange discoloration of urine
31
mechanism of amantadine in parkinsons
increase synthesis, release, or re-uptake of dopamine from surviving neurons
32
AE of amantadine
Livedo Reticularis (lace like purplish discoloration of skin)
33
contraindications/caution that should be taken in patient taken amantadine
caution in patients with history of seizures and heart failure
34
antimuscarinics used in treatment of parkinsons
Benztropine | Trihexyphenidyl
35
AE of the antimuscarinics
benztropine and trihexyphenidyl xerostomia, pupillary dilation, dry mouth, other effects associated with anticholinergics
36
contraindication of antimuscarinics
benztropine and trihexyphenidyl Glaucoma Prostatic Hypertrophy Pyloric Stenosis
37
most effective symptomatic treatment of Parkinsons
Levodopa with Carbidopa
38
reduce motor fluctuations in patients with advanced disease
MAOI and COMT-I
39
used for control of tremor and drooling
antimuscarinics